Welcome to the The Immunisation Update on-demand module series – designed to keep clinicians confidently informed of the latest vaccination evidence, recommendations, and clinical guidance to support best patient care.
Topic Summary
In these presentations, GPs will update their immunisation knowledge and clinical practice using the latest evidence‑based insights from leading experts. This module strengthens clinicians’ ability to apply current vaccine recommendations, make informed decisions, and manage immunisation‑related issues across all ages with greater confidence, accuracy, and safety.
Angela Newbound, Immunisation Education Consultant, outlines key provider updates, including PCV21 supply constraints, COVID-19 vaccines moving to the NIP, influenza data and measles exposure management. Travel medicine expert, Dr Deb Mills, then discusses the latest global dengue incidence and reviews the newly TGA-approved vaccine, covering effectiveness, eligibility, side effects, cost and assessing travellers’ risk.
Learning Objectives
- Update management guidelines with recommendations to changes for daily clinical practices
- Discuss new concepts, assessments, and management of common clinical issues and how these will impact clinical practice
- Create improved management strategies, and safety systems in treatment plans
- Evaluate the relative merits of treatment options and diagnostic tests to ensure better patient care and safety
CPD and Accreditation
This activity is accredited with the RACGP and ACRRM for up to 1 hour in the Educational Activities (EA) category. For RACGP and ACRRM members, Healthed will upload CPD hours on your behalf within four (4) weeks of the this activity’s completion.
All learners can track their Healthed learning and download a CPD Statement as evidence of completion, which may support self‑claimed professional development with your professional body.

Disclosure Statement
Takeda Pharmaceuticals Australia Pty Ltd has provided financial support towards this module.
The content has been independently developed without involvement or influence from Takeda. The information, views, and opinions presented are those of the presenter and may not reflect the views or opinions of Takeda.





